NIH has renewed and expanded its support for a USC-led consortium developing AI to decode and treat Alzheimer's using imaging and genomic data.
Key Details
- 1NIH total investment in the AI4AD project now totals $30.7 million, with a new $12.6 million award supporting the next phase (AI4AD2).
- 2AI4AD2 unites 10 investigators and 23 co-investigators from 10 institutions.
- 3The project integrates whole-genome sequencing, brain imaging, cognitive tests, and biological data from over 58,000 participants across 57 cohorts.
- 4New 'genomic language models' will analyze genomic sequences for disease-associated DNA changes.
- 5AI tools developed previously demonstrated >90% accuracy detecting Alzheimer's markers from over 80,000 brain scans.
- 6The initiative also focuses on inclusive, multi-ancestry research and genome-guided drug discovery.
Why It Matters
This large-scale effort could redefine Alzheimer's diagnosis and treatment by combining AI-powered brain imaging analysis with genomics, enabling precision medicine approaches. It also addresses diversity and reproducibility issues in neuroimaging and biomarker AI research.
Source
EurekAlert
Related News
•EurekAlert
FDA Approves Johns Hopkins AI Tool for Early Sepsis Detection
FDA clears an AI-driven system developed by Johns Hopkins to detect sepsis up to 48 hours earlier and reduce mortality rates.
•EurekAlert
AI-Driven Handheld Endomicroscope Enhances Early Cancer Detection
Researchers develop PrecisionView, a handheld AI-powered endomicroscope for real-time, high-resolution cancer diagnostics.
•EurekAlert
AI Model Uses EKG and EHR Data to Predict Sudden Cardiac Arrest
Researchers have developed AI models that analyze EKG and EHR data to predict risk of sudden cardiac arrest in the general population.